BioCentury
ARTICLE | Clinical News

LiquiVent: To begin Phase I trials shortly

August 2, 1993 7:00 AM UTC

Alliance Pharmaceuticals Inc. (ALLP) Product: LiquiVent, liquid perfluorochemical Indication: Respiratory Distress Syndrome in infants who have failed conventional therapy Status: To begin Phase I tri...